These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 15262127
21. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H, Debatin KM, Jeremias I. Cancer Res; 2005 Sep 01; 65(17):7888-95. PubMed ID: 16140959 [Abstract] [Full Text] [Related]
22. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR. Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135 [Abstract] [Full Text] [Related]
23. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer. Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K. Surgery; 2005 Jul 28; 138(1):71-7. PubMed ID: 16003319 [Abstract] [Full Text] [Related]
24. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. Song JH, Song DK, Herlyn M, Petruk KC, Hao C. Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653 [Abstract] [Full Text] [Related]
25. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW, Shah S. Asia Pac J Clin Nutr; 2005 Sep 15; 14(4):366-73. PubMed ID: 16326643 [Abstract] [Full Text] [Related]
28. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T. J Urol; 2001 Jan 15; 165(1):263-70. PubMed ID: 11125422 [Abstract] [Full Text] [Related]
31. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5. Horak P, Pils D, Kaider A, Pinter A, Elandt K, Sax C, Zielinski CC, Horvat R, Zeillinger R, Reinthaller A, Krainer M. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8585-91. PubMed ID: 16361541 [Abstract] [Full Text] [Related]
36. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L, Fang B. Cancer Gene Ther; 2005 Mar 01; 12(3):228-37. PubMed ID: 15550937 [Abstract] [Full Text] [Related]
37. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM. Oncogene; 2002 Oct 03; 21(44):6809-18. PubMed ID: 12360407 [Abstract] [Full Text] [Related]
39. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639 [Abstract] [Full Text] [Related]